drugset / Trial / NCT03950518
Novel Treatment of Advanced Hepatocellular Carcinoma
Phase 3
Unknown
300 enrolled
The First Affiliated Hospital of Zhengzhou University
Anyang Tumor Hospital · collabLuoyang Central Hospital · collabNanyang Central Hospital · collabPingdingshan Coal Medical Group General Hospital · collabSanmenxia Central Hospital · collabThird People's Hospital of Jiaozuo · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of arginine hydrochloride combined with Levamisole in the treatment of patients with hepatocellular carcinoma.
Timeline
- Start
- 2019-04-10
- Primary completion
- 2023-04-10
- Completion
- 2023-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Catequentinib | Small molecule | 12 mg | Oral |
| Subject | L-arginine | Small molecule | 40 g | — |
| Subject | Levamisole | Small molecule | 150 mg | — |